
Australian Research Targets Diabetes Hope for CF Patients
A breakthrough cystic fibrosis drug may also transform diabetes outcomes for 30% of Australian CF patients who develop the condition. New research will investigate whether Trikafta can prevent or slow cystic fibrosis-related diabetes.











%3Amax_bytes(150000)%3Astrip_icc()%2FMost-People-with-Diabetes-Donot-Get-Enough-of-This-Vitamin-35fe27031b1f4dd69a3740d767e2aa97.jpg)




